The main and novel observation of this study is that 1 year after the acute COVID-19 episode, patients with both PS and LC have evidence of systemic inflammation but the former shows increased levels of C3 protein and higher percentage of patients presented anti-nuclear autoantibodies whereas the latter has increased circulating levels of organ damage markers. This evidence concerns the gene C3 and COVID-19.